OvaScience
ClosedDiscovering new fertility treatment options.
Public · Cambridge, United States · Founded 2011 · $150.8M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 51–200
- Founded
- 2011
- Business Model
- B2C
- Total Funding
- $150.8M
- Last Round
- $50.0M Corporate RoundDec 2018
- Rounds
- 5
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 5 funding rounds and 7 investors for this company. The full record is or through the API.
About
OvaScience was a publicly traded biotechnology company focused on female infertility, applying novel science around egg precursor cells (EggPCSM cells) to improve egg quality and IVF outcomes. Founded in 2011 and based in Cambridge and later Waltham, Massachusetts, the company completed a reverse merger with Millendo Therapeutics in December 2018, ceasing to operate as OvaScience. The domain now redirects to an unrelated site.
Summary
OvaScience is a Biotech company based in Cambridge, United States, founded in 2011. It has raised $150.8M in total across 5 rounds, most recently a $50.0M Corporate Round in Dec 2018. Investors include General Catalyst, Bessemer Venture Partners and Longwood Fund.
Funding History
Dec 2018
Sign up to see all 5 events
Funding: Series A through Corporate Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/ovascience"><img src="https://indexed.vc/api/badge/company/ovascience" alt="OvaScience on Indexed.vc" width="260" height="76" /></a>

